Challenges Associated With the Recent Outbreaks of Wild-Type Poliovirus in Previously Polio-Free Countries

Human Vaccines and Immunotherapeutics - United States
doi 10.4161/hv.22489
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Intestinal Antibody Responses to a Live Oral Poliovirus Vaccine Challenge Among Adults Previously Immunized With Inactivated Polio Vaccine in Sweden

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2019English

Persistence of Antibodies Against Diphtheria, Tetanus, Pertussis, and Poliovirus Types I, II, and III Following Immunization With DTaP Combined With Inactivated Wild-Type Polio Vaccine (DTaP-wIPV)

Japanese Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Vaccine-Derived Poliovirus Surveillance in China During 2001–2013: The Potential Challenge for Maintaining Polio Free Status

BMC Infectious Diseases
Infectious Diseases
2017English

Socioeconomic Status and Vaccine Coverage During Wild-Type Poliovirus Emergence in Israel

Epidemiology and Infection
EpidemiologyInfectious Diseases
2016English

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)

Epidemiology and Vaccine Prevention
2017English

Molecular Characterization of a Wild Poliovirus Type 3 Epidemic in the Netherlands (1992 and 1993).

Journal of Clinical Microbiology
Microbiology
1995English

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

JAMA Oncology
Cancer ResearchOncology
2019English

Prolonged Excretion of Type-2 Poliovirus From a Primary Immune Deficient Patient During the Transition to a Type-2 Poliovirus-Free World, Israel, 2016

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2016English

First Report of a Persistent Oropharyngeal Infection of Type 2 Vaccine-Derived Poliovirus (iVDPV2) in a Primary Immune Deficient (PID) Patient After Eradication of Wild Type 2 Poliovirus

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy